Target intelligence / Profile preview

Intestinal bile salt and cholesterol micelles

Molecular classification
Lipid aggregate, Supramolecular assembly, Other
01

Overview

Intestinal bile salt and cholesterol micelles are complex supramolecular aggregates formed in the lumen of the small intestine, primarily composed of bile salts, phospholipids, monoglycerides, and fatty acids [1, 2]. Their primary biological function is to solubilize hydrophobic dietary lipids, such as cholesterol and fat-soluble vitamins, allowing them to traverse the unstirred water layer and reach the intestinal enterocytes for absorption [2]. These micelles are central to lipid metabolism and are a significant focal point in the treatment of hypercholesterolemia and cardiovascular disease [1]. Therapeutic interventions often involve disrupting these micelles or preventing the absorption of their contents. For instance, bile acid sequestrants bind to bile salts to prevent micelle formation and promote fecal excretion [1]. Plant sterols compete with cholesterol for space within the micellar core, reducing its bioavailability [3]. Additionally, drugs like ezetimibe target the transport of cholesterol from these micelles into the enterocyte [4]. By modulating the stability and composition of these micelles, clinicians can effectively lower systemic cholesterol levels and reduce the risk of atherosclerotic plaque formation [1, 4]. References: [1] StatPearls, Bile Acid Sequestrants; [2] StatPearls, Lipid Digestion and Absorption; [3] Journal of Nutrition, Mechanism of action of plant sterols; [4] Clinical Pharmacokinetics, Ezetimibe Review.

Other names
Mixed micellesBile acid micellesIntestinal mixed micellesBile salt-phospholipid-cholesterol aggregates
02

Mechanism of action

Bile acid sequestration and inhibition of micellar cholesterol solubilization

03

Biological functions

Lipid solubilizationCholesterol transportFat-soluble vitamin absorptionMicellar solubilization of dietary fats
04

Disease associations

HypercholesterolemiaCardiovascular diseaseAtherosclerosisDyslipidemiaCholelithiasis
05

Safety considerations

Malabsorption of fat-soluble vitamins (A, D, E, K)Gastrointestinal side effects (constipation, bloating)Drug-drug interactions due to non-specific binding
06

Interacting drugs

Cholestyramine

6 more in the full profile.

07

Biomarkers

Low-density lipoprotein cholesterol (LDL-C)Total cholesterolFecal bile acid excretion7-alpha-hydroxy-4-cholesten-3-one (C4)

Beyond the preview

Go deeper on Intestinal bile salt and cholesterol micelles.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal bile salt and cholesterol micelles.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call